Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi !

Synergistic effect of elevated lipoprotein (a) levels with inherited thrombophilia risk factors in children with arterial ishemic stroke (CROSBI ID 691735)

Prilog sa skupa u časopisu | sažetak izlaganja sa skupa | međunarodna recenzija

Herak Coen, Desiree ; Leniček Krleža, Jasna ; Topic Zrinski, Renata ; Radic Antolic, Margareta ; Horvat, Ivana ; Miloš, Marija ; Đuranović, Vlasta ; Zadro, Renata Synergistic effect of elevated lipoprotein (a) levels with inherited thrombophilia risk factors in children with arterial ishemic stroke // Journal of thrombosis and haemostasis. 2015. str. 665-665

Podaci o odgovornosti

Herak Coen, Desiree ; Leniček Krleža, Jasna ; Topic Zrinski, Renata ; Radic Antolic, Margareta ; Horvat, Ivana ; Miloš, Marija ; Đuranović, Vlasta ; Zadro, Renata

engleski

Synergistic effect of elevated lipoprotein (a) levels with inherited thrombophilia risk factors in children with arterial ishemic stroke

Background: Elevated lipoprotein (a) [Lp(a)] has been identified as a genetically determined risk factor for stroke in young adults. Recently, Sultan et al. (Int J Stroke 2014 ; 9:79–87) has also demonstrated a significant positive association between Lp(a) and arterial ischemic stroke (AIS) in children, whereas Kenet et al. (Circulation 2010 ; 21:1838–47) showed the highest odds ratio for combined genetic traits in first AIS onset. Aims: The aim was to investigate whether elevated Lp(a) levels are more frequently asssociated with already known inherited thrombophilia risk factors in children with a confirmed diagnosis of AIS. Methods: Study population comprised 61 children with AIS (perinatal n = 30, childhood n = 31). Lp(a) concentration was determined using a Tina-quant Lipoprotein(a) assay on Cobas c501 (Roche Diagnostics, Switzerland). Genotype analysis of FV Leiden, FV HR2, FII G20210A, b-fibrinogen -455G>A, FXIII-A Val34Leu, PAI-1 4G/5G, MTHFR C677T, MTHFR A1298C, ACE I/D, and apoE e2-4 was performed using a multilocus genotyping assay (CVD Strip Assay, ViennaLab, Austria). Human platelet alloantigens -1, -2, -3 and -5 were detected by ASO-PCR (Kluter et al. Vox Sang 1996 ; 71:121–5). Results: Children with AIS were divided into Lp(a) positive group (>0.3 g/ L) consisting of 16 (26%) children (median: 0.62 g/L), and Lp(a) negative group (<0.3 g/ L) consisting of 45 (74%) children (median: 0.09 g/L ). Elevated Lp(a) levels were statistically significantly associated with homozygosity for MTHFR A1298C (P = 0.036) and apo e2e3 genotype (P = 0.024). Unexpectedly, none of 7 identified FV Leiden carriers and 3 FV Leiden/FV HR2 heterozygotes were in the Lp(a) positive group, but their frequency was not statistically significant (P = 0.174 and P = 0.556, respectively). Conclusion: Among investigated inherited thrombophilia risk factors elevated Lp(a) levels may suggest synergistic effect with MTHFR 1298CC and apo e2e3 genotype and possible increased risk for AIS onset.

Lp(a), stroke, children, inherited thrombophilia

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o prilogu

665-665.

2015.

nije evidentirano

objavljeno

Podaci o matičnoj publikaciji

Journal of thrombosis and haemostasis

1538-7933

1538-7836

Podaci o skupu

XXV Congress of the International Society on Thrombosis and Haemostasis ISTH 2015

poster

20.06.2015-25.06.2015

Toronto, Kanada

Povezanost rada

Temeljne medicinske znanosti

Indeksiranost